 |
 |

Calciphylaxis in Secondary HyperparathyroidismDiagnosis and Parathyroidectomy
Quan-Yang Duh, MD;
Robert C. Lim, MD;
Orlo H. Clark, MD
Arch Surg. 1991;126(10):1213-1219.
Abstract
 |  |
Calciphylaxis is a rare, severe complication of secondary hyperparathyroidism. Patients present with painful, violaceous, mottled skin lesions of the upper and lower extremities, which become necrotic and produce nonhealing ulcers. Gangrene of fingers and toes frequently requires amputation, produces nonhealing wounds, and can lead to sepsis and death. We reviewed the clinical course of five patients with calciphylaxis treated in our institution. The three men and two women (aged 47 to 72 years) had secondary hyperparathyroidism from chronic renal failure. All patients had severe pruritus, painful ulcers, and severe hyperphosphatemia with elevated serum calcium-phosphate product (>12 mmol2/L2), but the serum parathyroid hormone levels were only moderately elevated. Most patients had medial calcification of medium and small blood vessels, and some had soft-tissue calcification visible on roentgenography. Treatment consisted of local wound care, antibiotics, phosphate-binding agents, and parathyroidectomy. Two patients died of uncontrollable sepsis. The three survivors had dramatic improvement of pain and ulcers after parathyroidectomy. Calciphylaxis is a limb- and lifethreatening complication of secondary hyperparathyroidism. Diagnosis can be made by recognizing the characteristic painful skin lesions, ulcers, and gangrene of the digits, and patients should be treated with subtotal parathyroidectomy.
(Arch Surg. 1991;126:1213-1219)
Author Affiliations
From the Surgical Service, Veterans Affairs Medical Center, San Francisco, and the Department of Surgery, University of California, San Francisco.
Footnotes
Accepted for publication June 30, 1991.
Presented at the 62nd Annual Scientific Session of the Pacific Coast Surgical Association, Pebble Beach, Calif, February 18, 1991, and in part, as a poster, at the 12th Annual Meeting of the American Society for Bone and Mineral Research, Atlanta, Ga, August 30, 1990.
Reprint requests to Veterans Affairs Medical Center, Surgical Service (112), 4150 Clement St, San Francisco, CA 94121 (Dr Duh).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Contribution of Bone and Mineral Abnormalities to Cardiovascular Disease in Patients with Chronic Kidney Disease
Raggi and Kleerekoper
CJASN 2008;3:836-843.
ABSTRACT
| FULL TEXT
Hyperbaric oxygen in the treatment of calciphylaxis: a case series
Podymow et al.
Nephrol Dial Transplant 2001;16:2176-2180.
ABSTRACT
| FULL TEXT
Calciphylaxis with facial involvement
Mathur et al.
Nephrol Dial Transplant 2001;16:2256-2257.
FULL TEXT
Calciphylaxis
Mathur et al.
Postgrad. Med. J. 2001;77:557-561.
ABSTRACT
| FULL TEXT
Calciphylaxis: a favorable outcome with hyperbaric oxygen
Dean and Werman
Vasc Med 1998;3:115-120.
ABSTRACT
Calciphylaxis in Three Patients With End-Stage Renal Disease
Ivker et al.
Arch Dermatol 1995;131:63-68.
ABSTRACT
Tumoral Calcinosis: Controversies in the Etiology and Alternatives in the Treatment
Tezelman et al.
Arch Surg 1993;128:737-745.
ABSTRACT
|